1-3 of 3
Nancy Bunin
Close
Sort by
Journal Articles

Tabelecleucel for EBV + PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol

Clinical Trials & Observations
Sarah Nikiforow, Jennifer S. Whangbo, Ran Reshef, Donald E. Tsai, Nancy Bunin, Rolla Abu-Arja, Kris Michael Mahadeo, Wen-Kai Weng, Koen Van Besien, David Loeb, Sunita Dwivedy Nasta, Eneida R. Nemecek, Weizhi Zhao, Yan Sun, Faith Galderisi, Justin Wahlstrom, Aditi Mehta, Laurence Gamelin, Rajani Dinavahi, Susan Prockop
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3001–3012.
https://doi.org/10.1182/bloodadvances.2023011626
Published: 2024
Includes: Supplemental data
Journal Articles

Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophy

Clinical Trials & Observations
Robert Chiesa, Jaap Jan Boelens, Christine N. Duncan, Jörn-Sven Kühl, Caroline Sevin, Neena Kapoor, Vinod K. Prasad, Caroline A. Lindemans, Simon A. Jones, Hernan M. Amartino, Mattia Algeri, Nancy Bunin, Cristina Diaz-de-Heredia, Daniel J. Loes, Esther Shamir, Alison Timm, Elizabeth McNeil, Andrew C. Dietz, Paul J. Orchard
Journal: Blood Advances
Blood Adv (2022) 6 (5): 1512–1524.
https://doi.org/10.1182/bloodadvances.2021005294
Published: 2022
Includes: Supplemental data
Journal Articles

Unrelated donor α/β T cell– and B cell–depleted HSCT for the treatment of pediatric acute leukemia

Clinical Trials & Observations
Allison Barz Leahy, Yimei Li, Julie-An Talano, Caitlin W. Elgarten, Alix E. Seif, Yongping Wang, Bryon Johnson, Dimitri S. Monos, Stephan Kadauke, Timothy S. Olson, Jason Freedman, Lisa Wray, Stephan A. Grupp, Nancy Bunin
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1175–1185.
https://doi.org/10.1182/bloodadvances.2021005492
Published: 2022
Includes: Supplemental data